A validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: Auditory brainstem response and distortion product otoacoustic emissions
Sensorineural hearing loss due to ototoxic drugs remains as a conflict as the treatment option with aminoglycosides. Ototoxic mouse model was produced with the administration of ototoxic drugs aminoglycoside kanamycin and loop-diuretic furosemide, thus validation of auditory function of the mouse mo...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Toxicology Research and Application |
Online Access: | https://doi.org/10.1177/23978473211016816 |
id |
doaj-a51b174a5b184a79a9399676e20ea30d |
---|---|
record_format |
Article |
spelling |
doaj-a51b174a5b184a79a9399676e20ea30d2021-05-13T03:03:28ZengSAGE PublishingToxicology Research and Application2397-84732021-05-01510.1177/23978473211016816A validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: Auditory brainstem response and distortion product otoacoustic emissionsYeji Ahn0Jin Sil Choi1Dae Hyun Kim2Temuulen Batsaikhan3Young Joon Seo4 Department of Otorhinolaryngology, Wonju College of Medicine, Yonsei University, Wonju, South Korea Department of Otorhinolaryngology, Wonju College of Medicine, Yonsei University, Wonju, South Korea Department of Medicine, Wonju College of Medicine, Yonsei University, Wonju, South Korea Department of Otorhinolaryngology, Wonju College of Medicine, Yonsei University, Wonju, South Korea Department of Otorhinolaryngology, Wonju College of Medicine, Yonsei University, Wonju, South KoreaSensorineural hearing loss due to ototoxic drugs remains as a conflict as the treatment option with aminoglycosides. Ototoxic mouse model was produced with the administration of ototoxic drugs aminoglycoside kanamycin and loop-diuretic furosemide, thus validation of auditory function of the mouse model is needed to determine the efficacy of the drugs. Kanamycin sulfate 550 mg/kg (VWR life sciences, PA, USA) and furosemide 130 mg/kg (Lasix, Handok, Korea) were administered through subcutaneous and intraperitoneal injection respectively. Auditory brainstem response and distortion otoacoustic emission tests were performed on days 3,5,7,10,14 post administration of the ototoxic drug. Thresholds in response to the stimulus given in the auditory brainstem recordings and distortion otoacoustic emission tests were obtained. The hearing threshold shift to high stimulus intensity was observed post administration of the ototoxic drug. Latency of the ABR peak waves were recorded and analyzed, latency delay was observed as hearing threshold increases. These findings will further support in the application of this animal model in various studies regarding ototoxic hearing loss.https://doi.org/10.1177/23978473211016816 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yeji Ahn Jin Sil Choi Dae Hyun Kim Temuulen Batsaikhan Young Joon Seo |
spellingShingle |
Yeji Ahn Jin Sil Choi Dae Hyun Kim Temuulen Batsaikhan Young Joon Seo A validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: Auditory brainstem response and distortion product otoacoustic emissions Toxicology Research and Application |
author_facet |
Yeji Ahn Jin Sil Choi Dae Hyun Kim Temuulen Batsaikhan Young Joon Seo |
author_sort |
Yeji Ahn |
title |
A validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: Auditory brainstem response and distortion product otoacoustic emissions |
title_short |
A validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: Auditory brainstem response and distortion product otoacoustic emissions |
title_full |
A validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: Auditory brainstem response and distortion product otoacoustic emissions |
title_fullStr |
A validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: Auditory brainstem response and distortion product otoacoustic emissions |
title_full_unstemmed |
A validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: Auditory brainstem response and distortion product otoacoustic emissions |
title_sort |
validation study of auditory function in an aminoglycoside-furosemide ototoxicity mouse model: auditory brainstem response and distortion product otoacoustic emissions |
publisher |
SAGE Publishing |
series |
Toxicology Research and Application |
issn |
2397-8473 |
publishDate |
2021-05-01 |
description |
Sensorineural hearing loss due to ototoxic drugs remains as a conflict as the treatment option with aminoglycosides. Ototoxic mouse model was produced with the administration of ototoxic drugs aminoglycoside kanamycin and loop-diuretic furosemide, thus validation of auditory function of the mouse model is needed to determine the efficacy of the drugs. Kanamycin sulfate 550 mg/kg (VWR life sciences, PA, USA) and furosemide 130 mg/kg (Lasix, Handok, Korea) were administered through subcutaneous and intraperitoneal injection respectively. Auditory brainstem response and distortion otoacoustic emission tests were performed on days 3,5,7,10,14 post administration of the ototoxic drug. Thresholds in response to the stimulus given in the auditory brainstem recordings and distortion otoacoustic emission tests were obtained. The hearing threshold shift to high stimulus intensity was observed post administration of the ototoxic drug. Latency of the ABR peak waves were recorded and analyzed, latency delay was observed as hearing threshold increases. These findings will further support in the application of this animal model in various studies regarding ototoxic hearing loss. |
url |
https://doi.org/10.1177/23978473211016816 |
work_keys_str_mv |
AT yejiahn avalidationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT jinsilchoi avalidationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT daehyunkim avalidationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT temuulenbatsaikhan avalidationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT youngjoonseo avalidationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT yejiahn validationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT jinsilchoi validationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT daehyunkim validationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT temuulenbatsaikhan validationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions AT youngjoonseo validationstudyofauditoryfunctioninanaminoglycosidefurosemideototoxicitymousemodelauditorybrainstemresponseanddistortionproductotoacousticemissions |
_version_ |
1721442916790960128 |